Literature DB >> 5116204

Secretion of glucagon from the isolated, perfused canine pancreas.

J Iversen.   

Abstract

Using the isolated, perfused canine pancreas preparation, previously described, the interrelationship of the secretion of pancreatic glucagon and insulin was studied after stimulation with glucose, gastrointestinal hormones, and the amino acid arginine. The results confirm the concept that pancreatic glucagon is a hormone of "glucose need" and suggest that it may be important in a moment to moment control of glucoregulation. The secretion of pancreatic glucagon was stimulated after infusion of gastrin, pancreozymin, and arginine, while no increase was associated with secretin infusion. The magnitude of the increase was closely related to the glucose concentration present in the perfusion medium, being higher and more pronounced during perfusion with low concentrations of glucose (25 mg/100 ml or 50 mg/100 ml). Stimulation of insulin secretion was seen after glucose, gastrin, pancreozymin, secretin, and arginine. The magnitude of the increase was again closely related to the glucose concentration present, this time being higher and more pronounced during perfusion with high glucose concentrations (150 mg/100 ml). Secretion of both pancreatic hormones always followed a biphasic response pattern after the stimuli mentioned, similar to the characteristic release pattern previously described for insulin after an increment in glucose concentration. In order to elucidate whether endogenous pancreatic glucagon possesses an insulinogenic action, as it has been shown to be the case with the administration of exogenous pancreatic glucagon, the time interrelationship of the secretion of pancreatic glucagon and insulin was investigated by determining the initial rise of the hormones after stimulation with gastrin, pancreozymin, and arginine. The rise of glucagon and insulin occurred simultaneously, i.e. inside a 10 sec period. This does not, however, exclude with certainty an insulinogenic role of pancreatic glucagon.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116204      PMCID: PMC292146          DOI: 10.1172/JCI106706

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Effect of glucagon, cyclic 3',5'-adenosine monophosphate and its dibutyryl derivative on amino acid uptake by the isolated perfused rat liver.

Authors:  J W Chambers; R H Georg; A D Bass
Journal:  Endocrinology       Date:  1970-08       Impact factor: 4.736

2.  Effects of glucagon on amino acid transport and utilization in the perfused rat liver.

Authors:  L E Mallette; J H Exton
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

3.  Immunochemical glucagon in human pancreas, gut, and plasma.

Authors:  E Samols; J Tyler; C Megyesi; V Marks
Journal:  Lancet       Date:  1966-10-01       Impact factor: 79.321

4.  Studies on the secretion of pancreatic glucagon.

Authors:  T M Chesney; J G Schofield
Journal:  Diabetes       Date:  1969-09       Impact factor: 9.461

Review 5.  Gastrin and its activities.

Authors:  M I Grossman
Journal:  Nature       Date:  1970-12-19       Impact factor: 49.962

6.  Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion.

Authors:  W A Müller; G R Faloona; E Aguilar-Parada; R H Unger
Journal:  N Engl J Med       Date:  1970-07-16       Impact factor: 91.245

7.  Primary secretion of insulin and secondary release of glucagon from the isolated perfused rat pancreas following stimulation with pancreozymin.

Authors:  R D Fussgänger; K Straub; R Goberna; P Jaros; K E Schröder; S Raptis; E F Pfeiffer
Journal:  Horm Metab Res       Date:  1969-07       Impact factor: 2.936

8.  Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon.

Authors:  E Samols; G Marri; V Marks
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

9.  Basal plasma glucagon levels of man.

Authors:  J E Sokal; E Z Ezdinli
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

10.  Insulin responses to glucose: evidence for a two pool system in man.

Authors:  D Porte; A A Pupo
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  33 in total

1.  The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas.

Authors:  E Ipp; R E Dobbs; V Harris; A Arimura; W Vale; R H Unger
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

2.  Calcium, glucose and glucagon release.

Authors:  J Iversen; K Hermansen
Journal:  Diabetologia       Date:  1977-08       Impact factor: 10.122

3.  Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone.

Authors:  J C Henquin; P Malvaux; A E Lambert
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

4.  A threshold distribution hypothesis for packet storage of insulin and its mathematical modeling.

Authors:  G M Grodsky
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

5.  Glucagon release induced by pancreatic nerve stimulation in the dog.

Authors:  E B Marliss; L Girardier; J Seydoux; C B Wollheim; Y Kanazawa; L Orci; A E Renold; D Porte
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

6.  The role of the autonomic innervation in the control of glucagon release during hypoglycaemia in the calf.

Authors:  S R Bloom; A V Edwards; N J Vaughan
Journal:  J Physiol       Date:  1974-02       Impact factor: 5.182

7.  Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.

Authors:  M Otsuki; C Sakamoto; H Yuu; M Maeda; S Morita; A Ohki; N Kobayashi; K Terashi; K Okano; S Baba
Journal:  J Clin Invest       Date:  1979-03       Impact factor: 14.808

8.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs.

Authors:  D H Wasserman; H L Lickley; M Vranic
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.